Clinical Pharmacology in Drug Development, 2023
Safety, Pharmacokinetics, and Antifibrotic Activity of CC‐90001 (BMS‐986360), a c‐Jun N‐Terminal Kinase Inhibitor, in Pulmonary Fibrosis

Horan G., Ye Y., Adams M. et al.

JNCI: Journal of the National Cancer Institute, 2023
Circulating proteome for pulmonary nodule malignancy

Khodayari Moez E., Warkentin M., Brhane Y. et al.

PLOS ONE, 2023
Identification of potential biomarkers in active Lyme borreliosis

Tjernberg I., Lager M., Furset Jensen G. et al.

Brain, 2023
CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease

van der Ende E., In ‘t Veld S., Hanskamp I. et al.

Journal of Proteome Research, 2023
Cerebrospinal Fluid Protein Biomarker Discovery in CLN3

Dang Do A., Sleat D., Campbell K. et al.

Diabetologia, 2023
Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts

Zanetti D., Stell L., Gustafsson S. et al.

iScience, 2023
Altered anti-viral immune responses in monocytes in overweight heavy drinkers

Kim A., Ortega-Ribera M., McMullen M. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2023
Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy

Kraaijenhof J., Opstal T., Cornel J. et al.

Allergy, 2023
Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis

Mitamura Y., Reiger M., Kim J. et al.

Brain Communications, 2023
Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study

Jakimovski D., Qureshi F., Ramanathan M. et al.

Diabetologia, 2023
Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study

Luo H., Bauer A., Nano J. et al.

AJOG Global Reports, 2023
Comparative predictive power of serum vs plasma proteomic signatures in feto-maternal medicine

Espinosa C., Ali S., Khan W. et al.

Cytokine, 2023
Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves’ ophthalmopathy in comparison to hyperthyroid patients without Graves’ ophthalmopathy

Khamisi S., Anders Karlsson F., Ljunggren ?. et al.

Journal of Neuroimmunology, 2023
Inflammatory biomarkers differentiate the stage of maturation in chronic subdural hematomas

Svedung Wettervik T., Sundblom J., Ronne-Engström E.

Journal of Translational Medicine, 2023
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function

Iosef C., Knauer M., Nicholson M. et al.

PLOS ONE, 2023
Adipokines and risk of rheumatoid arthritis: A two-sample multivariable Mendelian randomisation study

Vasileiadis G., Sayols S., Zhao S. et al.

Nature Communications, 2023
Persistent serum protein signatures define an inflammatory subcategory of long COVID

Talla A., Vasaikar S., Szeto G. et al.

Journal of Crohn's and Colitis, 2023
Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease

Sabino J., Tarassishin L., Eisele C. et al.

BMC Neurology, 2023
Inflammatory-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy

Maglinger B., Harp J., Frank J. et al.

Frontiers in Immunology, 2023
Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology

Stiglund N., Hagström H., Stål P. et al.